Figure S2 from Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Ian Ganly, Yongxing Gong et al.|Unknown|2023Cited by 0
Table S1 from Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Ian Ganly, Yongxing Gong et al.|Unknown|2023Cited by 0
Table S1 from Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Ian Ganly, James A. Fagin et al.|Unknown|2023Cited by 0
Figure S3 from Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Ian Ganly, Yongxing Gong et al.|Unknown|2023Cited by 0
Figure S1 from Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Ian Ganly, Yongxing Gong et al.|Unknown|2023Cited by 0